Financial PerformanceAlkermes reported positive growth for its commercialized product portfolio in 3Q with total net sales of $273 million showing 18% YoY growth and total revenues of $378.1 million.
Orexin Market OpportunityThe market opportunity for orexins is considered very large, with room for multiple players.
Orexin-2 Mechanism PotentialThe orexin-2 mechanism offers the potential to address an underlying cause of the disease for narcolepsy type 1 patients, as well as significant symptom relief for patients with narcolepsy type 2 and IH patients.